Busca en nuestro sitio web
Apoyanos

Harris Gleckman

Our people — Associate
Harris Gleckman es miembro sénior en el Center for Governance and Sustainability de la Universidad de Massachusetts, Boston, y director de Benchmark Environmental Consulting. Gleckman es doctor en Sociología por la Universidad de Brandeis. Trabajó en el Centro de Corporaciones Transnacionales de la ONU, fue jefe de la oficina en Nueva York de la Conferencia de las Naciones Unidas sobre Comercio y Desarrollo (UNCTAD) y uno de los primeros miembros de la Conferencia de Monterey sobre Financiación del Desarrollo.

Últimos trabajos

  • Multistakeholderism Is it good for developing countries?

    Multistakeholderism
    Multistakeholderism: Is it good for developing countries?

    The preparations for the September 2024 Summit of the Future (SOTF) are well underway. In this process, the UN Secretary-General and most OECD countries argue that multistakeholderism should now be accepted as a part of global governance and multilateralism. This paper argues the opposite: multistakeholderism undermines multilateralism and limits the role of developing countries in global governance.

    Report de
    Harris Gleckman

  • The Three COVID crises and Multistakeholderism Impacts on the Global South

    • Multistakeholderism
    • COVID-19

    This new report from the Transnational Institute and Friends of the Earth International explores the role of multistakeholderism in the COVID crises, when multistakeholder initiatives, working outside the multilateral system, acted as governing bodies. A follow-up to COVAX, a joint study published in March 2021, this report situates COVID-related multistakeholder undertakings within the overall strategy of the Global North towards the Global South.

    Report de
    Harris Gleckman

  • How powerful pharmaceutical companies shaped the response to the pandemic Arun Kundnani in Conversation with Harris Gleckman

    • COVID-19
    • Multistakeholderism

    During the pandemic, the World Health Organisation and governments took a back seat and power was centred on corporate interests. Health was viewed not as a right or a necessity, but as a product to be marketed and sold. Even in the midst of a global health emergency, companies treated the ill and the vulnerable as consumers and vaccines as commodities, setting prices and production rates that maximise profit. How has this happened and what, if any, are the alternatives?

    Podcast de
    • Harris Gleckman
    • Arun Kundnani
Ver todo el trabajo de Harris Gleckman

Ideas en movimiento

Impulsa nuestra labor

Si deseas apoyar nuestro trabajo, considera realizar una donación. Nos comprometemos a que nuestra valiosa investigación esté accesible sin costo, pero para eso necesitamos de tu ayuda. Si todas las personas que leen nuestro contenido realizan una donación de tan solo €12 podremos apoyar nuestro trabajo durante tres años.

Done Ahora